ESC Premium Access

Late Breaking Science in Heart Failure 1

Event: ESC CONGRESS 2019
Topic: Chronic Heart Failure
Session type: Late-Breaking Science
Date: 2 September 2019
Time: 08:30 - 10:00

Congress Session

5 presentations in this session

Spironolactone in atrial fibrillation with preserved cardiac contractility

Speaker: Doctor E. Shantsila (Liverpool, GB)

Effects of Sacubitril-Valsartan Compared with Enalapril on Arterial Hemodynamics and Cardiac Remodeling in Patients with Heart Failure and Reduced Ejection Fraction

Speaker: Doctor A. Desai (Boston, US)

Effects of Angiotensin Receptor/Neprilysin Inhibitor Therapy on NT-proBNP and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction: Primary Results of the PROVE-HF Study

Speaker: Professor J. Januzzi (Boston, US)

Clinical effectiveness of primary prevention implantable defibrillators: results of the EU-CERT-ICD non-randomised, controlled, multicentre study

Speaker: Associate Professor M. Zabel (Gottingen, DE)

Clinical phenotypes, gender differences and adverse events associated with truncating variants in the Titin (TTN) gene

Speaker: Doctor M. Akhtar (London, GB)

5 speakers from this session

Doctor Eduard Shantsila

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
2 presentations
0 follower

Doctor Akshay Suvas Desai

Brigham and Women's Hospital, Boston (United States of America)
1 presentation
0 follower

Professor James Januzzi

Massachusetts General Hospital - Harvard Medical School, Boston (United States of America)
20 presentations
1 follower

Associate Professor Markus Zabel

Georg-August-University Gottingen/Heart Center, Department of Cardiology, Gottingen (Germany)
4 presentations
0 follower

Doctor Majid Akhtar

Barts Heart Centre, London (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk